As a complex syndrome, cachexia has different clinical manifestations;
anorexia appears to be one of the most frequent findings, together wi
th weight loss. Anorexia is the cause and partly the consequence of me
tabolic changes and of progressive undernourishment. In cancer cachexi
a, weight loss is associated with a marked decrease of food intake and
severe alteration of body composition. Malnourished cancer patients s
how a marked loss of adipose tissue and protein mass with BIA evidence
of decreased body cell mass and expansion of extracellular water. The
mechanisms of anorexia and cachexia are still a matter of debate, but
the possible involvement of cytokines in the pathogenesis of this syn
drome has opened up new possibilities for its understanding and treatm
ent. As a result of the multifactorial etiology of cancer cachexia/ano
rexia, therapies that stimulate appetite and promote greater food inta
ke, coupled with factors that influence metabolism and cytokine produc
tion may be an optimal therapeutic strategy. Of particular interest ap
pears to be the possible role played by fish oil in antagonizing the n
egative effects of cytokines. Future research in this field will help
clinicians develop new methods to treat patients who have disease-indu
ced starvation and wasting.